SIGACHI37.60

Sigachi Industries Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersLINCOLNTHEMISMEDBAJAJHCAREAMRUTANJANJAGSNPHARMWANBURYNGLFINEMcap ₹1,437 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations399.0488.2477.8470.9
Other Income11.720.58.35.3
Total Income410.6508.8486.1476.2
Expenses
+ Cost of Materials Consumed160.3235.3199.7192.8
+ Purchases of Stock-in-Trade40.03.129.532.7
+ Changes in Inventories-5.1-16.318.517.1
+ Employee Benefit Expense57.273.6110.4102.8
+ Finance Costs7.812.413.913.6
+ Depreciation & Amortisation10.815.817.617.3
+ Other Expenses70.092.566.079.4
Total Expenses340.9416.4455.6455.6
EBITDA76.7100.053.746.2
EBIT65.984.236.228.9
Profit
PBT before Exceptional Items69.892.330.520.6
+ Exceptional Items0.00.0-118.22.8
Pretax Income69.892.3-87.723.4
+ Current Tax12.114.52.44.9
+ Deferred Tax0.47.3-7.3-7.8
Tax Expense12.521.9-4.9-2.9
Net Income57.370.5-82.826.3
+ Net Income — Continuing Ops57.370.5-82.826.3
+ Other Comprehensive Income0.0-0.13.25.1
Total Comprehensive Income57.370.3-79.631.4
Net Income to Common57.269.6-81.825.4
Minority Interest0.10.9-1.01.0
Per Share
Basic EPS1.812.06-2.140.67
Diluted EPS1.542.06-2.140.67
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.13.25.1
+ Items NOT to be Reclassified to P&L0.0-0.7-0.1-0.1
+ Tax on Items NOT to be Reclassified-0.1-0.0-0.0
+ Tax on Items NOT to be Reclassified — alt tag0.0
+ Items to be Reclassified to P&L0.00.53.25.1
Comprehensive Income — Owners of Parent57.269.5-78.619.7
Comprehensive Income — Non-controlling Interests0.10.8-1.01.1
Per Share — as-filed variants
Basic EPS — Continuing Operations1.812.06-2.140.67
Diluted EPS — Continuing Operations1.542.06-2.140.67
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit203.8266.1230.1228.3
Gross Margin %51.0954.5048.1648.48
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)69.892.330.520.6
− Exceptional Items (reconciliation)0.00.0-118.22.8
Net Income Adj (tax-effected)57.370.528.823.5
EPS Adj1.812.060.740.60
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.00
Paid Up Equity Capital32.838.238.238.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.